FDA Inspection 1109687 — Alnylam Pharmaceuticals Inc.
The FDA completed an inspection of Alnylam Pharmaceuticals Inc. on Sep 13, 2019 in Cambridge, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 13, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cambridge, MA (United States)